GNE-317 is primarily utilized in the field of neuroscience research due to its ability to cross the blood-brain barrier effectively. It is often employed in studies focusing on neurodegenerative diseases, such as Alzheimer's and Parkinson's, to investigate potential therapeutic effects. Researchers use it to modulate specific cellular pathways implicated in these conditions, aiding in the development of targeted treatments. Additionally, its properties make it a valuable tool for exploring drug delivery mechanisms to the central nervous system, enhancing the understanding of how compounds can be optimized for brain-related therapies.